EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 1: treatment and monitoring recommendations - Nast - 2020 - Journal of the European Academy of Dermatology and Venereology - Wiley Online Library
Biologics: Matching Drugs to Patients
Frontiers | Advances in Therapeutic Drug Monitoring in Biologic Therapies for Pediatric Inflammatory Bowel Disease
Clinical Practice Guidelines for the Medical Management of Nonhospitalized Ulcerative Colitis: The Toronto Consensus
Clinical Practice of Adalimumab and Infliximab Biosimilar Treatment in Adult Patients With Crohn's Disease
Optimizing biologic therapy in IBD: how essential is therapeutic drug monitoring? | Nature Reviews Gastroenterology & Hepatology
Frontiers | Head-to-Head Comparison of Etanercept vs. Adalimumab in the Treatment of Ankylosing Spondylitis: An Open-Label Randomized Controlled Crossover Clinical Trial
Algorithm for use of reactive therapeutic drug monitoring in IBD... | Download Scientific Diagram
Immunopharmacologic Monitoring of Therapeutic Serum Antibodies I. Policy Description II. Related Policies III. Indications and/o
1 Scottish Biologic Therapeutic Drug Monitoring Service –Gastroenterology Guidance The purpose of this document is to provide
Proactive Monitoring of Adalimumab Trough Concentration Associated With Increased Clinical Remission in Children With Crohn's Disease Compared With Reactive Monitoring - ScienceDirect
Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers - eBioMedicine
Therapeutic monitoring of adalimumab at non-trough levels in patients with inflammatory bowel disease | PLOS ONE
New Zealand Society of Gastroenterology Guidelines on Therapeutic Drug Monitoring in Inflammatory Bowel Disease
Therapeutic Drug Monitoring of anti-TNF therapies Infliximab and Adalimumab Infliximab Drug Levels
Therapeutic drug monitoring of biologics in inflammatory bowel disease: unmet needs and future perspectives - The Lancet Gastroenterology & Hepatology
American Gastroenterological Association (AGA) on Twitter: "New clinical guideline on role of therapeutic drug monitoring in the management of #IBD now available in @AGA_Gastro https://t.co/yzwtV2FaEj https://t.co/IxiVz1xfST" / Twitter
NASPGHAN17 Therapeutic Drug Monitoring Associated with Increased Clinical Remission | gutsandgrowth
Medical management of moderate to severe luminal and perianal fistulizing Crohn's disease - American Gastroenterological Association
Comparison between adalimumab introduction and methotrexate dose escalation in patients with inadequately controlled psoriatic arthritis (CONTROL): a randomised, open-label, two-part, phase 4 study - The Lancet Rheumatology
AGA Guideline: Therapeutic drug monitoring in IBD | GI and Hepatology News
Adalimumab | Crohn's & Colitis UK
JCM | Free Full-Text | A Practical Guide to Therapeutic Drug Monitoring of Biologic Medications for Inflammatory Bowel Disease
Disease Monitoring in Inflammatory Bowel Disease: Evolving Principles and Possibilities - ScienceDirect
